ARCHER DANIELS MIDLAND CO
SC 13D/A, 1998-04-02
FATS & OILS
Previous: APPLIED POWER INC, 10-Q, 1998-04-02
Next: AYDIN CORP, DEF 14A, 1998-04-02



     PAGE 1
                        UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
                              
                        SCHEDULE 13D
                              
                              
          Under the Securities Exchange Act of 1934
                              
                     (Amendment No. 4)*
                              
                          IBP, Inc.
    ____________________________________________________
                      (Name of Issuer)
                              
                        COMMON STOCK
    ____________________________________________________
               (Title of Class of Securities)
                              
                         449223-10-6
       ______________________________________________
                       (CUSIP Number)
                              
D. J. Smith, Vice President, Secretary and General Counsel
Archer-Daniels-Midland Company, 4666 Faries Parkway, P. O.
Box 1470, Decatur, IL 62525, Telephone: (217)424-6183
____________________________________________________________

(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)

                   March 25, 1998
___________________________________________________
 (Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject
of this Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box __.

Check the following box if a fee is being paid with the
statement ___.  (A fee is not required only if the reporting
person: (1) has a previous statement on file reporting
beneficial ownership of more than five percent of the class
of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership
of five percent or less of such class.) (See Rule 13d-7.)

Note: Six copies of this statement, including all exhibits,
should be filed with the commission.  See Rule 13d-1(a) for
other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of Securities, and for any subsequent
amendment containing information which would alter
disclosures provided in a prior cover page.

This information required on the remainder of this cover
page shall not be deemed to be "filed" for the purpose of
Section 18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that Section of the
Act but shall be subject to all other provisions of the Act
(however, see the Notes).
1

     PAGE 2
                        SCHEDULE 13D
CUSIP NO. 449223-10-6                   Page 2 of 5 Pages
________________________________________________________
1  NAME OF REPORTING PERSON
     S. S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
                              
   Archer-Daniels-Midland Company
   I.R.S. Identification No. 41-0129150
____________________________________________________________
2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP * (a)__
                                                      (b)__
____________________________________________________________
3  SEC USE ONLY
____________________________________________________________
4  SOURCE OF FUNDS *
   WC
____________________________________________________________
5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED
   PURSUANT TO ITEMS 2(d) OR 2(E)  X
   See Appendix I
____________________________________________________________
6  CITIZENSHIP OR PLACE OF ORGANIZATION
   DELAWARE
____________________________________________________________
             |7  SOLE VOTING POWER
  NUMBER OF  |   10,124,300
   SHARES    |___________________________________________
BENEFICIALLY |8    SHARED VOTING POWER
   OWNED BY  |   -0-
     EACH    |___________________________________________
   REPORTING |9  SOLE DISPOSITIVE POWER
    PERSON   |   10,124,300
   WITH      |___________________________________________
             |10  SHARED DISPOSITIVE POWER
             |   -0-
____________________________________________________________
11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
    PERSON 10,124,300(Appendix II shows all transactions
    within the past sixty (60) days)
____________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW(11)EXCLUDES
   CERTAIN SHARES *__
____________________________________________________________
 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   10.937 based on 92,565,108 shares outstanding
____________________________________________________________
14 TYPE OF REPORTING PERSON *
   CO
____________________________________________________________
* SEE INSTRUCTIONS BEFORE FILLING OUT!
2





PAGE 3

CUSIP NO. 449223-10-6                   Page 3 of 5 Pages



                          SIGNATURE
                              
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
Statement is true, complete and correct.

Dated: April 2, 1998



                    ARCHER-DANIELS-MIDLAND COMPANY
                         /s/ D. J. SMITH
                      By:  D. J. Smith
                         Its Vice President, Secretary
                          and General Counsel
3





     PAGE 4

CUSIP NO. 449223-10-6      Page 4 of 5 Pages

                         APPENDIX I

     On October 15, 1996, the Company pled guilty to a two
count information in the Northern District of Illinois
pursuant to an agreement with the Department of Justice.
This information states that the Company engaged in
anticompetitive conduct in connection with the sale of
lysine and citric acid.  In connection with its agreement
the Company paid the United States a fine of $70 million
with respect to lysine and $30 million with respect to
citric acid.
4



     PAGE 5

CUSIP NO. 449223-10-6                 Page 5 of 5 Pages
                         APPENDIX II
                              
           Marketable Securities - Purchase Detail
                              
                         From:  01/30/98
                           To:  04/01/98


          Trade          # of           Tran
          Date           Shares         Price

                   Description:  IBP, Inc.

        02/04/98         25,000         20.000
        02/05/98         18,100         20.000
        03/12/98          6,600         23.125
        03/12/98         25,000         23.250
        03/24/98         43,400         23.125
        03/25/98         50,000         23.000
        03/26/98         41,400         22.875
        03/26/98          8,600         22.813
        03/27/98         48,800         22.750
        03/27/98         16,000         22.813
        03/30/98         50,000         22.750
        03/30/98         50,000         22.625
        03/31/98         50,000         22.500
5







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission